CONSTRAINT-INDUCED MOVEMENT THERAPY VERSUS CROSS EDUCATION IN CHILDREN WITH CEREBRAL PALSY
Launched by IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY · Nov 25, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of therapy to see which one helps children with hemiplegic cerebral palsy improve their movement. One therapy is called Constraint-Induced Movement Therapy (CIMT), which focuses on using the affected limb more, while the other is Strength Training for the non-affected limb, known as cross-education. The trial will include children aged 4 to 10 who have mild to moderate mobility issues (levels I, II, and III on the GMFCS scale).
Participants will take part in either therapy for 8 weeks, attending three sessions each week. Researchers will measure their motor performance before starting and at the end of the trial to see how much progress they’ve made. It's important to note that children who have had certain recent treatments or specific medical conditions may not be able to participate. This trial is a great opportunity to explore new ways to help children with cerebral palsy improve their movement skills in a supportive environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children with hemiplegic cerebral palsy aged age between 4 and 10.
- • 2. (GMFCS) levels I, II and III.
- • 3. Able to follow therapist instructions during training session.
- Exclusion Criteria:
- • 1. Lack of patient's cooperation.
- • 2. Difficulty wearing constraint method due to severe joint deformation or/and contracture.
- • 3. Patients were treated with botulinum toxin during the last 3 months.
- • 4. Seizure disorder not fully controlled by medication.
About Imam Abdulrahman Bin Faisal University
Imam Abdulrahman Bin Faisal University (IAU) is a distinguished educational institution located in Saudi Arabia, dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in medical education and community health, IAU actively engages in multidisciplinary studies that aim to enhance patient outcomes and contribute to evidence-based practices. The university's clinical trial initiatives are supported by a robust framework of ethical standards and regulatory compliance, ensuring the integrity and safety of its research endeavors. By fostering collaboration among researchers, healthcare professionals, and industry partners, IAU aims to drive significant advancements in medical science and improve the overall quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dammam, , Saudi Arabia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported